We are live on !
Find out more
Thomaspartners Portfolio holdings
AUM
$13.7B
Turnover
6.41%
1-Year Est. Return
8.42%
This Fund
S&P 500
This Quarter Est. Return
+1.37%
1 Year Est. Return
+8.42%
3 Year Est. Return
+26.06%
5 Year Est. Return
+60.14%
10 Year Est. Return
–
AUM
$11.6B
AUM Growth
+$789M
(+7.3%)
Cap. Flow
+$661M
Cap. Flow % of AUM
Cap. Flow %
5.68%
Top 10 Holdings %
Top 10 Hldgs %
27.05%
Holding
80
New
1
Increased
51
Reduced
22
Closed
5
Avg Time Held
3.6
years
Top 10 Avg Time Held
0.8
years
Top 20 Avg Time Held
1.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$166M |
| 2 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$56.2M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$33.5M |
| 4 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$33.4M |
| 5 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$28.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Deere & Co
DE
|
+$93.7M |
| 2 |
Leggett & Platt
LEG
|
+$56.8M |
| 3 |
Abbott
ABT
|
+$9.45M |
| 4 |
Kimberly-Clark
KMB
|
+$1.25M |
| 5 |
Illinois Tool Works
ITW
|
+$876K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.6% |
| 2 | Healthcare | 13.45% |
| 3 | Industrials | 13.34% |
| 4 | Financials | 11.93% |
| 5 | Consumer Staples | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Johnson & Johnson
JNJ
$612B
| $393M | 3.38% |
2,974,040
+114,860
| +4% | +$14.7M |
2013 Q2
16 quarters
|
|
2
ExxonMobil
XOM
$733B
| $337M | 2.9% |
4,173,527
+255,700
| +7% | +$20.9M |
2013 Q2
16 quarters
|
|
3
PPG Industries
PPG
$23.9B
| $319M | 2.74% |
2,898,717
+117,365
| +4% | +$12.7M |
2013 Q2
16 quarters
|
|
4
Chevron
CVX
$440B
| $314M | 2.7% |
3,005,794
+190,563
| +7% | +$20.2M |
2013 Q2
16 quarters
|
|
5
RTX Corp
RTX
$259B
| $306M | 2.63% |
3,987,826
+172,143
| +5% | +$12.9M |
2013 Q2
16 quarters
|
|
6
Alerian MLP ETF
AMLP
$12.6B
| $300M | 2.58% |
5,024,399
+442,636
| +10% | +$27M |
2013 Q2
16 quarters
|
|
7
Microsoft
MSFT
$3.96T
| $298M | 2.56% |
4,316,197
+128,376
| +3% | +$8.81M |
2013 Q2
16 quarters
|
|
8
Novartis
NVS
$285B
| $296M | 2.54% |
3,954,851
+215,065
| +6% | +$15.2M |
2013 Q2
16 quarters
|
|
9
Truist Financial
TFC
$56.6B
| $295M | 2.53% |
6,487,282
+354,239
| +6% | +$15.4M |
2013 Q2
16 quarters
|
|
10
Wells Fargo
WFC
$246B
| $290M | 2.49% |
5,225,968
+268,580
| +5% | +$14.4M |
2013 Q2
16 quarters
|
|
11
IBM
IBM
$223B
| $279M | 2.4% |
1,899,329
+129,691
| +7% | +$19.6M |
2013 Q2
16 quarters
|
|
12
Philip Morris
PM
$313B
| $275M | 2.36% |
2,341,956
+42,373
| +2% | +$4.91M |
2013 Q2
16 quarters
|
|
13
Texas Instruments
TXN
$252B
| $272M | 2.34% |
3,538,689
+122,078
| +4% | +$9.8M |
2015 Q3
7 quarters
|
|
14
Verizon
VZ
$183B
| $271M | 2.33% |
6,074,768
+437,346
| +8% | +$20.4M |
2013 Q2
16 quarters
|
|
15
BCE
BCE
$18.5B
| $262M | 2.25% |
5,819,776
+346,357
| +6% | +$15.6M |
2013 Q2
16 quarters
|
|
16
Diageo
DEO
$52B
| $255M | 2.2% |
2,131,939
+94,581
| +5% | +$11.3M |
2013 Q2
16 quarters
|
|
17
Eversource Energy
ES
$24.3B
| $250M | 2.15% |
4,123,093
+175,660
| +4% | +$10.7M |
2013 Q2
16 quarters
|
|
|
18
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.4B
| $244M | 2.1% |
4,637,548
+1,068,558
| +30% | +$56.2M |
2013 Q2
16 quarters
|
|
19
JPMorgan Chase
JPM
$886B
| $243M | 2.09% |
2,655,966
+83,538
| +3% | +$7.21M |
2013 Q2
16 quarters
|
|
20
VF Corp
VFC
$6.74B
| $242M | 2.08% |
4,460,236
+270,184
| +6% | +$13.9M |
2013 Q2
16 quarters
|
|
21
Pfizer
PFE
$168B
| $239M | 2.05% |
7,490,974
+494,547
| +7% | +$15.6M |
2013 Q2
16 quarters
|
|
|
22
Abbott
ABT
$180B
| $238M | 2.04% |
4,891,137
-208,856
| -4% | -$9.45M |
2013 Q2
16 quarters
|
|
23
AT&T
T
$159B
| $230M | 1.98% |
8,076,902
+513,017
| +7% | +$15.1M |
2013 Q2
16 quarters
|
|
24
Becton Dickinson
BDX
$52B
| $230M | 1.98% |
1,207,398
+44,714
| +4% | +$8.17M |
2013 Q2
16 quarters
|
|
25
Procter & Gamble
PG
$366B
| $230M | 1.97% |
2,633,638
+150,072
| +6% | +$13.2M |
2013 Q2
16 quarters
|
|
Similar funds
ID
VAM
PJC
Thomaspartners's Q2 2017 Portfolio in Review
As of Q2 2017, Thomaspartners held 80 positions worth $11.6B, up 7.3% from $10.8B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Thomaspartners deployed $661M of net new capital in Q2 2017, opening 1 new position and adding to 51 existing holdings. Its largest new stake was CVS Health: 2,105,729 shares worth $169M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Deere & Co, an estimated $93.7M trimmed.
- Thomaspartners's largest Q2 2017 buy was CVS Health: 2,105,729 shares worth $169M.
- Thomaspartners added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2017, an estimated $56.2M increase.
- Thomaspartners's biggest Q2 2017 reduction was Deere & Co, cutting an estimated $93.7M.
- Thomaspartners fully exited Vanguard Total Bond Market in Q2 2017, selling an estimated $303K.
- Thomaspartners's ten largest holdings make up 27% of its $11.6B portfolio in Q2 2017.
- Thomaspartners opened 1 new position and closed 5 in Q2 2017.
- Thomaspartners's portfolio value rose 7.3% quarter-over-quarter to $11.6B.
Based on Thomaspartners's 13F filing for Q2 2017, filed 11 Aug 2017.